NVCR241220C00015000 Option on Novocure

NVCR Stock  USD 18.85  0.41  2.22%   
Novocure's latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.81 with a put-to-call open interest ratio of 0.33 over 56 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on June 20th 2025.

Open Interest Against June 20th 2025 Option Contracts

The chart above shows Novocure's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Novocure's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Novocure's option, there is no secondary market available for investors to trade.

Novocure Maximum Pain Price Across 2025-06-20 Option Contracts

Max pain occurs when Novocure's market makers reach a net positive position across all Novocure's options at a strike price where option holders stand to lose the most money. By contrast, Novocure's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Novocure

Analyzing Novocure's in-the-money options over time can help investors to take a profitable long position in Novocure regardless of its overall volatility. This is especially true when Novocure's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Novocure's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Novocure's stock while costing only a fraction of its price.

Novocure In The Money Call Balance

When Novocure's strike price is surpassing the current stock price, the option contract against Novocure stock is said to be in the money. When it comes to buying Novocure's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Novocure are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Novocure Current Options Market Mood

Novocure's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Novocure Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Novocure's options investors are not very successful. Novocure's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Novocure contract

Base on the Rule 16, the options market is currently suggesting that Novocure will have an average daily up or down price movement of about 0.0506% per day over the life of the 2025-06-20 option contract. With Novocure trading at USD 18.85, that is roughly USD 0.009543. If you think that the market is fully incorporating Novocure's daily price movement you should consider buying Novocure options at the current volatility level of 0.81%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Novocure options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Novocure calls. Remember, the seller must deliver Novocure stock to the call owner when a call is exercised.

Novocure Option Chain

When Novocure's strike price is surpassing the current stock price, the option contract against Novocure stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Novocure's option chain is a display of a range of information that helps investors for ways to trade options on Novocure. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Novocure. It also shows strike prices and maturity days for a Novocure against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
NVCR250620C0004500030245.00.0 - 1.450.18Out
Call
NVCR250620C0004000024140.00.0 - 0.350.27Out
Call
NVCR250620C00039000539.00.0 - 1.252.95Out
Call
NVCR250620C00038000138.00.0 - 1.250.1Out
Call
NVCR250620C00037000637.00.0 - 1.251.65Out
Call
NVCR250620C0003600010336.00.0 - 0.950.15Out
Call
NVCR250620C0003500012235.00.0 - 0.90.18Out
Call
NVCR250620C000340003134.00.0 - 1.01.75Out
Call
NVCR250620C00033000033.00.0 - 1.251.25Out
Call
NVCR250620C000320002632.00.0 - 1.10.4Out
Call
NVCR250620C00031000831.00.0 - 0.350.7Out
Call
NVCR250620C000300006630.00.1 - 0.250.2Out
Call
NVCR250620C0002900014529.00.1 - 0.451.55Out
Call
NVCR250620C000280008028.00.05 - 0.450.35Out
Call
NVCR250620C0002700012527.00.15 - 0.71.5Out
Call
NVCR250620C000260007226.00.25 - 0.40.55Out
Call
NVCR250620C0002500010725.00.3 - 0.50.7Out
Call
NVCR250620C000240004124.00.4 - 0.650.65Out
Call
NVCR250620C000230009323.00.5 - 0.851.1Out
Call
NVCR250620C0002200035122.00.7 - 1.050.7Out
Call
NVCR250620C00021000821.00.85 - 1.351.55Out
Call
NVCR250620C000200002920.01.25 - 1.651.77Out
Call
NVCR250620C00019000719.01.6 - 2.054.5Out
Call
NVCR250620C000180002018.02.05 - 2.552.15In
Call
NVCR250620C000170003017.02.65 - 3.13.26In
Call
NVCR250620C00015000115.03.4 - 5.05.15In
Call
NVCR250620C00014000214.04.2 - 5.65.24In
Call
NVCR250620C0000500015.012.4 - 14.126.0In
 Put
NVCR250620P00045000045.024.8 - 28.124.8In
 Put
NVCR250620P00040000040.020.5 - 22.820.5In
 Put
NVCR250620P00039000039.018.9 - 21.818.9In
 Put
NVCR250620P00038000038.018.0 - 21.318.0In
 Put
NVCR250620P00037000037.017.4 - 19.517.4In
 Put
NVCR250620P00036000036.016.1 - 19.316.1In
 Put
NVCR250620P00035000035.014.9 - 18.214.9In
 Put
NVCR250620P00034000034.014.4 - 16.814.4In
 Put
NVCR250620P00033000033.013.5 - 15.813.5In
 Put
NVCR250620P00032000332.013.0 - 15.06.4In
 Put
NVCR250620P000300003830.011.1 - 12.310.4In
 Put
NVCR250620P000290003029.09.6 - 12.05.0In
 Put
NVCR250620P000280002928.09.0 - 10.24.9In
 Put
NVCR250620P000270002827.08.3 - 9.17.25In
 Put
NVCR250620P000260005126.07.2 - 8.45.1In
 Put
NVCR250620P000250004525.06.5 - 6.97.97In
 Put
NVCR250620P000240007524.05.6 - 6.04.64In
 Put
NVCR250620P000230001123.04.9 - 5.22.7In
 Put
NVCR250620P000220003322.04.0 - 4.42.85In
 Put
NVCR250620P0002100011021.03.3 - 3.72.15In
 Put
NVCR250620P000200003020.02.6 - 3.03.9In
 Put
NVCR250620P000190001319.01.8 - 2.651.9In
 Put
NVCR250620P00018000318.01.15 - 2.351.65Out
 Put
NVCR250620P000170001417.01.05 - 1.452.1Out
 Put
NVCR250620P000160001016.00.25 - 1.951.19Out
 Put
NVCR250620P0001500013715.00.4 - 0.80.75Out
 Put
NVCR250620P00013000513.00.1 - 1.31.76Out
 Put
NVCR250620P0000900019.00.0 - 1.350.65Out

Novocure Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Novocure Market Cap Over Time

   Market Cap   
       Timeline  

Novocure Total Stockholder Equity

Total Stockholder Equity

289.42 Million

At this time, Novocure's Total Stockholder Equity is relatively stable compared to the past year.

Novocure Corporate Management

Piet MDHead VPProfile
Barak BenAryeGeneral CounselProfile
William BurkeChief OfficerProfile
Frank LeonardExecutive OncologyProfile
Christoph BrackmannChief OfficerProfile
Uri MDChief OfficerProfile

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.